glp 1 agonists vs sglt2 inhibitors Recommendations for SGLT2i versus GLP-1 RA on the basis of kidney GLP1 Receptor Agonists vs SGLT2-I
Description
At $199 per month through TrimRxcompared to $349 ongoing for brand-nameyou save $1,800 per year while receiving the same active ingredient with full medical oversight
95% CI: 0.321.00), though no significant effect was found on all-cause mortality (HR 0.81
Importantly, the triagonist also lowered fasting blood glucose levels and improved glucose tolerance without inducing hypoglycemia
Perez-Garcia A, Hurtado-Carneiro V, Herrero-De-Dios C, Dongil P, Garcia-Maurino JE, Sanchez MD, et al
These secondary targets are not interchangeable
